Short-term ROCK targeting improves cytotoxic drug efficacy in primary and metastatic pancreatic cancers.
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
Published OnlineFirst April 14, 2017
Thank you for sharing this Cancer Discovery article.
NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.